彭澎;李雷;

• 1:中国医学科学院北京协和医学院北京协和医院妇产科

摘要(Abstract)：

<正>本文对2015年10月和11月发表于重要的国际综合性期刊、妇产科期刊以及妇科肿瘤学期刊上有关妇科恶性肿瘤的重要文献进行简要介绍。这些文献的内容涉及各种妇科恶性肿瘤的病因、预防、诊断、治疗、生活质量以及预后评估等各个方面。因文献数量众多,限于篇幅仅选取样本量较大、证据质量较高

关键词(KeyWords)： 妇科恶性肿瘤;随机对照研究

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 彭澎;李雷;

参考文献(References)：

• [1]Sundstrm K,Ploner A,Arnheim-Dahlstrm L,et al.Interactions between high-and low-risk HPV types reduce the risk of squamous cervical cancer[J].J Natl Cancer Inst,2015,107:djv185.
• [2]Desmond A,Kurian AW,Gabree M,et al.Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment[J].JAMA Oncol,2015,1:943-951.
• [3]Song H,Dicks E,Ramus SJ,et al.Contribution of germline mutations in the RAD51B,RAD51C,and RAD51D genes to ovarian cancer in the population[J].J Clin Oncol,2015,33:2901-2907.
• [4]Hung R,J Ulrich CM,Goode EL,et al.Cross cancer genomic investigation of inflammation pathway for five common cancers:lung,ovary,prostate,breast,and colorectal cancer[J].J Natl Cancer Inst,2015,107:djv246.
• [5]Dorton BJ,Vitonis AF,Feldman S.Comparing cervical cytology and histology among human papillomavirus-vaccinated and-unvaccinated women in an academic colposcopy clinic[J].Obstet Gynecol,2015,126:785-791.
• [6]Vandeperre A,Van Limbergen E,Leunen K,et al.Paraaortic lymph node metastases in locally advanced cervical cancer:Comparison between surgical staging and imaging[J].Gynecol Oncol,2015,138:299-303.
• [7]Arnaboldi P,Santoro L,Mazzocco K,et al.The paradox of pelvic exenteration:the interaction of clinical and psychological variables[J].Int J Gynecol Cancer,2015,25:1534-1540.
• [8]Kohler C,Mustea A,Marnitz S,et al.Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer:results of a prospective randomized trial[J].Am J Obstet Gynecol,2015,213:503 e1-e7.
• [9]Chiantera V,Vizzielli G,Lucidi A,et al.Laparoscopic radical hysterectomy in cervical cancer as total mesometrial resection(L-TMMR):a multicentric experience[J].Gynecol Oncol,2015,139:47-51.
• [10]Todo Y,Yamazaki H,Takeshita S,et al.Close relationship between removal of circumflex iliac nodes to distal external iliac nodes and postoperative lower-extremity lymphedema in uterine corpus malignant tumors[J].Gynecol Oncol,2015,139:160-164.
• [11]Aghajanian C,Goff B,Nycum LR,et al.Final overall survival and safety analysis of OCEANS,a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer[J].Gynecol Oncol,2015,139:10-16.
• [12]Buda A,Lissoni AA,Floriani I,et al.Long-term clinical benefits of neoadjuvant chemotherapy in women with locally advanced cervical cancer:validity of pathological response as surrogate endpoint of survival[J].Int J Gynecol Cancer,2015,25:1468-1475.
• [13]Rapoport BL,Chasen MR,Gridelli C,et al.Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer:two randomised,active-controlled,double-blind,phase 3 trials[J].Lancet Oncol,2015,16:1079-1089.
• [14]Schwartzberg LS,Modiano MR,Rapoport BL,et al.Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer:a randomised,activecontrolled,double-blind,phase 3 trial[J].Lancet Oncol,2015,16:1071-1078.
• [15]Chu MM,Ma Y,Tse KY,et al.Cyclophosphamide,hydroxyurea,actinomycin d,methotrexate,and vincristine in the treatment of gestational trophoblastic neoplasia[J].Int JGynecol Cancer,2015,25:498-503.
• [16]Ho JC,Allen PK,Jhingran A,et al.Management of nodal recurrences of endometrial cancer with IMRT[J].Gynecol Oncol,2015,139:40-46.
• [17]Ferriss JS,Java JJ,Bookman MA,et al.Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian,fallopian tube and peritoneal cancers:an NRG Oncology/GOG study[J].Gynecol Oncol,2015,139:17-22.
• [18]Oza AM,Cook AD,Pfisterer J,et al.Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer(ICON7):overall survival results of a phase 3randomised trial[J].Lancet Oncol,2015,16:928-936.
• [19]Symonds RP,Gourley C,Davidson S,et al.Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer(CIRCCa):a randomised,double-blind,placebo-controlled phase 2 trial[J].Lancet Oncol,2015,16:1515-1524.
• [20]Trimble CL,Morrow MP,Kraynyak KA,et al.Safety,efficacy,and immunogenicity of VGX-3100,a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18E6 and E7 proteins for cervical intraepithelial neoplasia 2/3:a randomised,double-blind,placebo-controlled phase 2b trial[J].Lancet,2015,386:2078-2088.
• [21]Chan JL,Letourneau J,Salem W,et al.Sexual satisfaction and quality of life in survivors of localized cervical and ovarian cancers following fertility-sparing surgery[J].Gynecol Oncol,2015,139:141-147.
• [22]Melin J,Heinavaara S,Malila N,et al.Adverse Obstetric Outcomes Among Early-Onset Cancer Survivors in Finland[J].Obstet Gynecol,2015,126:803-810.
• [23]Felix AS,Scott Mc Meekin D,Mutch D,et al.Associations between etiologic factors and mortality after endometrial cancer diagnosis:The NRG Oncology/Gynecologic Oncology Group 210 trial[J].Gynecol Oncol,2015,139:70-76.
• [24]Pol FJM,Zusterzeel PLM,van Ham MAPC,et al.Satellite lymphovascular space invasion:An independent risk factor in early stage cervical cancer[J].Gynecol Oncol,2015,138:579-584.
• [25]Andersen CL,Eskelund CW,Siersma VD,et al.Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer?[J].Gynecol Oncol,2015,139:312-318.